Nebenwirkungen · Cabazitaxel Accord
Cabazitaxel Accord 20 mg/ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 7–8
HOS-144887 · Präparat HOS-099284
The incidences from the pooled analysis of these 3 trials are presented below and in the tabulated list. The most common all grades adverse reactions were anaemia (99.0%), leukopenia (93.0%), neutropenia (87.9%), thrombocytopenia (41.1%), diarrhoea (42.1%), fatigue (25.0%) and asthenia 7 (15.4%).The most common grade ≥3 adverse reactions occurring in at least 5% of patients were neutropenia (73.1%), leukopenia (59.5%), anaemia (12.0%), febrile neutropenia (8.0%) and diarrhoea (4.7%).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-07T12:43:00Z · SHA-256 e94990ee8411fa544039e204cf256f3e804b1eb52641ffca9b2a77499ea7c894 · Passage 48c86fc3048fd6f0a019909e2ff2fb977965de465ebbddc054c99b2e74fae5ba · Zeichen 391–932 im Abschnitt